Skip Navigation



JAC Advance Access published online on October 21, 2004

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh451
© 2004 by The British Society for Antimicrobial Chemotherapy
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
54/6/1158    most recent
dkh451v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in J. Antimicrob. Chemother.
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Frippiat, F.
Right arrow Articles by Derue, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frippiat, F.
Right arrow Articles by Derue, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Correspondence

Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections

Frédéric Frippiat 1*, Françoise Meunier 2, and Geneviève Derue 3

1 Department of Internal Medicine, Centre Hospitalier Jolimont-Lobbes, rue Ferrer 159, B-7100 Haine-Saint-Paul, Belgium; Department of Internal Medicine, Centre Hospitalier Universitaire du Sart Tilman, Bâtiment B 35 Sart-Tilman, B-4000 Liège, Belgium
2 Department of Microbiology, Centre Hospitalier Jolimont-Lobbes, rue Ferrer 159, B-7100 Haine-Saint-Paul, Belgium
3 Department of Internal Medicine, Centre Hospitalier Jolimont-Lobbes, rue Ferrer 159, B-7100 Haine-Saint-Paul, Belgium

* To whom correspondence should be addressed.
Frédéric Frippiat, E-mail: f.frippiat{at}chu.ulg.ac.be



This article has no Abstract. Keywords: moxifloxacin; rifampicin; bone infections; joint infections.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in J. Antimicrob. Chemother.:

Treatment of Gram-positive bone and joint infection: authors' response
Elizabeth S. R. Darley and Alasdair P. MacGowan
J. Antimicrob. Chemother. 2004 10.1093/jac/dkh461. [Abstract]  



This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
O. Grossi, J. Caillon, C. Arvieux, C. Jacqueline, D. Bugnon, G. Potel, and A. Hamel
In Vivo Efficacy of Moxifloxacin Compared with Cloxacillin and Vancomycin in a Staphylococcus aureus Rabbit Arthritis Experimental Model
Antimicrob. Agents Chemother., September 1, 2007; 51(9): 3401 - 3403.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.